<?xml version="1.0"?>
<oembed><version>1.0</version><provider_name>Market Newsdesk</provider_name><provider_url>https://www.marketnewsdesk.com</provider_url><author_name>Newsdesk</author_name><author_url>https://www.marketnewsdesk.com/index.php/author/newsdesk/</author_url><title>Guerbet: 2020 annual results - Market Newsdesk</title><type>rich</type><width>600</width><height>338</height><html>&lt;blockquote class="wp-embedded-content" data-secret="LTjMarZG0K"&gt;&lt;a href="https://www.marketnewsdesk.com/index.php/guerbet-2020-annual-results/"&gt;Guerbet: 2020 annual results&lt;/a&gt;&lt;/blockquote&gt;&lt;iframe sandbox="allow-scripts" security="restricted" src="https://www.marketnewsdesk.com/index.php/guerbet-2020-annual-results/embed/#?secret=LTjMarZG0K" width="600" height="338" title="&#x201C;Guerbet: 2020 annual results&#x201D; &#x2014; Market Newsdesk" data-secret="LTjMarZG0K" frameborder="0" marginwidth="0" marginheight="0" scrolling="no" class="wp-embedded-content"&gt;&lt;/iframe&gt;&lt;script&gt;
/*! This file is auto-generated */
!function(d,l){"use strict";l.querySelector&amp;&amp;d.addEventListener&amp;&amp;"undefined"!=typeof URL&amp;&amp;(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&amp;&amp;!/[^a-zA-Z0-9]/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret="'+t.secret+'"]'),o=l.querySelectorAll('blockquote[data-secret="'+t.secret+'"]'),c=new RegExp("^https?:$","i"),i=0;i&lt;o.length;i++)o[i].style.display="none";for(i=0;i&lt;a.length;i++)s=a[i],e.source===s.contentWindow&amp;&amp;(s.removeAttribute("style"),"height"===t.message?(1e3&lt;(r=parseInt(t.value,10))?r=1e3:~~r&lt;200&amp;&amp;(r=200),s.height=r):"link"===t.message&amp;&amp;(r=new URL(s.getAttribute("src")),n=new URL(t.value),c.test(n.protocol))&amp;&amp;n.host===r.host&amp;&amp;l.activeElement===s&amp;&amp;(d.top.location.href=t.value))}},d.addEventListener("message",d.wp.receiveEmbedMessage,!1),l.addEventListener("DOMContentLoaded",function(){for(var e,t,s=l.querySelectorAll("iframe.wp-embedded-content"),r=0;r&lt;s.length;r++)(t=(e=s[r]).getAttribute("data-secret"))||(t=Math.random().toString(36).substring(2,12),e.src+="#?secret="+t,e.setAttribute("data-secret",t)),e.contentWindow.postMessage({message:"ready",secret:t},"*")},!1)))}(window,document);
//# sourceURL=https://www.marketnewsdesk.com/wp-includes/js/wp-embed.min.js
&lt;/script&gt;
</html><description>2020 annual results Revenue in line with forecasts despite the health crisis: -12.8% at current exchange rates at &#x20AC;712.3&#xA0;million -10.0% at constant exchange rates (CER)(1)&#xA0; Resilient EBITDA(2) margin at 14.1%&#xA0; Proposed dividend maintained at &#x20AC;0.70/share Higher free cash flow at &#x20AC;40 million with significant working capital improvement Reduction of net debt to &#x20AC;257 million Confirmation of the strategic roadmap in 2021: Strong growth in Interventional Imaging and delivery systems Reinforcement of the Group&#x2019;s positions in the APAC region Finalization of clinical studies and continuation of industrial investments for Gadopiclenol Continued investments in Artificial Intelligence A favorable financial outlook: Revenue expected to increase in 2021 despite an ongoing health crisis Extension of 50% of the cost reduction implemented in 2020 Villepinte, &hellip; Continue reading ""</description><thumbnail_url>https://www.globenewswire.com/newsroom/ti?nf=MTAwMDQ3NDM1MSM0MDA5MDAxNjIjMTAxMTUwNQ==</thumbnail_url></oembed>
